Clinical trial Recruiting at 1 site Interventional Ages 21 to 55

Do a single nicotine pouch affect cigarette craving and brain response to smoking cues

Official title: Cue-Exposure Response Evaluation: Brain Reactivity to ONPs

Run by University of Southern California · NCT07698470 · Data updated 2026-11-12

This study tests whether a single 6 mg oral nicotine pouch can reduce craving and alter prefrontal brain responses to smoking cues in adults who smoke cigarettes.

Quick facts

Study typeInterventional
Ages21 Years to 55 Years
SexAll
Enrollment45 (estimated)
SponsorUniversity of Southern California
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedApril 30, 2026
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedJuly 13, 2026
Trial IDNCT07698470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21-55 who smoke cigarettes daily or on most days, have a CO breath sample ≥10 ppm, and FTND score ≥5, and are willing to try an oral nicotine pouch while abstaining from nicotine before visits.

Probably not a fit

Individuals with very low nicotine dependence, non-smokers, or those unable to abstain from nicotine before visits may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm, within-subject study that examines the acute effects of an oral nicotine pouch on cigarette craving and prefrontal neural activity in response to smoking cues. After overnight nicotine abstinence, participants complete baseline craving assessments and a brain-imaging task using fNIRS while viewing smoking-related cues, then receive a 6 mg oral nicotine pouch and repeat the task. The study uses a baseline and experimental visit design with strict abstinence verification and a standardized cue-reactivity protocol. Enrollment targets adults aged 21-55 who smoke regularly and meet moderate-to-high nicotine dependence criteria. Primary outcomes focus on changes in self-reported craving and neural cue reactivity following pouch use.

Why it matters

Potential benefit: If successful, ONPs could offer a lower-risk option to reduce cigarette craving and cue-induced brain responses, aiding smoking reduction efforts.

How similar studies have gone: Prior research in nicotine replacement and cue-reactivity supports the potential for pharmacologic aids to modulate craving and neural responses, though this specific ONP and fNIRS approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21 years - 55 years
* Self-reported use of cigarettes within the past 30 days
* Biochemical confirmation of cigarette use:

  o Carbon monoxide (CO) breath sample ≥10 ppm
* Fagerström Test for Nicotine Dependence (FTND) score ≥5, indicating moderate to high nicotine dependence
* Fluent in English
* Willing to try an oral nicotine pouch
* Willing to abstain from nicotine for at least 12 hours prior to each experimental session

Exclusion Criteria:

* Age younger than 21 years or older than 55 years
* Biochemical evidence inconsistent with recent cigarette use:

  o CO breath sample \<10 ppm
* Expressed intent to reduce or quit nicotine use within the next 30 days
* History of medical conditions contraindicated for nicotine use (e.g., uncontrolled hypertension, recent cardiac events)
* Primary use of non-cigarette products (e.g., cigars, pipe tobacco, smokeless tobacco)
* Prior use of oral nicotine products in their lifetime

Where it's running

  • University of Southern California - 3641 Watt Way (HNB B22)
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Natalia Peraza — University of Southern California
  • Study coordinator: USC Nicotine and Tobacco Studies
  • Email: USCONPStudy@gmail.com
  • Phone: 213-821-0807

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.